Bellicum Pharmaceuticals Inc. (BLCM) Slipped -5.04% or -0.4 To Price $7.53 On Wednesday


Bellicum Pharmaceuticals Inc. (BLCM) slipped -5.04% or -0.4 to $7.53. It is near 203213 shares traded, which is 26.8% compare to the average total volume 758217. The market cap of BLCM is $322.83 million. The year to date change is -19.13%. The 52 week price range is from $5.02 to $13.3. Price of BLCM have changed -3.41% during last week. It have changed -11.79% over last month, -11.59% over last 3 months, -6.26% over last 6 months and -33.86% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BLCM is 8.15. It is 8.23% above current price. The 200-day Moving Averages for BLCM is 8.42. It is 11.82% above current price. The 52-week High is 13.3. It is 76.63% from the current price. The 52-week Low is 5.02. It is -33.33% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of BLCM is 4.28 on 2018-06-29. Short % to float is 9.09%. There are some statistics of BLCM. It is has market cap $322.83 million. The share outstanding is 42.87 million. The average volume is 758217. The revenue is 126000. It has 243.31M cash and 61.62M in debt. The percent of top 15 Institution holding is 42.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BLCM is -79.93%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BLCM is -55.35%.


Tags:

Share this post